These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 22781112)
1. [Analysis of the status of DACH1 gene promoter methylation in endometrial carcinoma and its clinical significance]. Deng XC; Li SR; Zhang Q; Zhou CJ; Yang QF; Jiang J; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):263-7. PubMed ID: 22781112 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma. Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454 [TBL] [Abstract][Full Text] [Related]
4. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma]. Zhou YN; Xu CP; Han B; Ji R Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136 [TBL] [Abstract][Full Text] [Related]
5. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma. Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461 [TBL] [Abstract][Full Text] [Related]
6. [Expression of P53, P63, and C-erbB-2 in endometrioid adenocarcinoma and their clinicopathological significance]. Hu WF; Liu MQ; Zhao Q Ai Zheng; 2004 Sep; 23(9):1021-5. PubMed ID: 15363194 [TBL] [Abstract][Full Text] [Related]
7. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines. Jiang Y; Tong D; Lou G; Zhang Y; Geng J Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070 [TBL] [Abstract][Full Text] [Related]
8. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma. Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926 [TBL] [Abstract][Full Text] [Related]
9. Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer. Chang YS; Wang L; Liu D; Mao L; Hong WK; Khuri FR; Lee HY Clin Cancer Res; 2002 Dec; 8(12):3669-75. PubMed ID: 12473575 [TBL] [Abstract][Full Text] [Related]
10. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues]. Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251 [TBL] [Abstract][Full Text] [Related]
11. [Significance of methylation and abnormal expression of p16 gene in endometrial carcinoma]. Yuan JR; Fu SB; Fu H; Li P Yi Chuan Xue Bao; 2004 May; 31(5):454-9. PubMed ID: 15478604 [TBL] [Abstract][Full Text] [Related]
12. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma. Saito T; Nishimura M; Yamasaki H; Kudo R Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599 [TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the GATA genes in lung cancer. Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of DACH1 induces the invasion and metastasis of gastric cancer by activating TGF-β signalling. Yan W; Wu K; Herman JG; Brock MV; Zhou Y; Lu Y; Zhang Z; Yang Y; Guo M J Cell Mol Med; 2014 Dec; 18(12):2499-511. PubMed ID: 24912879 [TBL] [Abstract][Full Text] [Related]
15. [Expression and methylation of adenomatous polyposis coli gene in endometrioid adenocarcinoma]. Qian B; Ke PQ; Wang L; Liu WJ; Li MX Ai Zheng; 2008 Jun; 27(6):585-9. PubMed ID: 18570730 [TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor B gene inactivation and CpG hypermethylation in human uterine endometrial cancer. Sasaki M; Dharia A; Oh BR; Tanaka Y; Fujimoto S; Dahiya R Cancer Res; 2001 Jan; 61(1):97-102. PubMed ID: 11196205 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Akahira J; Suzuki F; Suzuki T; Miura I; Kamogawa N; Miki Y; Ito K; Yaegashi N; Sasano H Pathol Int; 2007 Nov; 57(11):725-33. PubMed ID: 17922684 [TBL] [Abstract][Full Text] [Related]
18. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis. Salvesen HB; Das S; Akslen LA Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444 [TBL] [Abstract][Full Text] [Related]
19. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer. Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646 [TBL] [Abstract][Full Text] [Related]
20. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Brevet M; Fucks D; Chatelain D; Regimbeau JM; Delcenserie R; Sevestre H; Ouadid-Ahidouch H Pancreas; 2009 Aug; 38(6):649-54. PubMed ID: 19465885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]